NCT02319278View on ClinicalTrials.gov

DEtection of Cellular Inflammation With FERumoxytol in the HEART

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Cardiac TransplantCardiac SarcoidMyocarditisHealthy Volunteers
Interventions
DRUG

Ferumoxytol

Infusion following between paired MRI scans

Trial Locations (3)

Unknown

Royal Infirmary of Edinburgh, Edinburgh

Golden Jubilee National Hospital, Glasgow

Royal Brompton Hospital, London

All Listed Sponsors
collaborator

Royal Infirmary of Edinburgh

OTHER

collaborator

Golden Jubilee National Hospital

OTHER_GOV

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

University of Edinburgh

OTHER

NCT02319278 - DEtection of Cellular Inflammation With FERumoxytol in the HEART | Biotech Hunter | Biotech Hunter